Applied dna receives approval for tr8(tm) pharmacogenomic (pgx) testing service from new york state department of health

Stony brook, ny / accesswire / june 13, 2024 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced that the new york state department of health ("nysdoh") approved the company's tr8™ pgx ("tr8") pharmacogenomic (pgx) testing service. the company is currently in discussions to provide large-scale testing to enterprise customers, healthcare networks, and concierge physicians seeking to add pgx testing to their test menu.
DNA Ratings Summary
DNA Quant Ranking